Search

The rapid rise in the application of novel treatment techniques, such as intensity-modulated radiotherapy (IMRT), motivated us to survey the status of Korea's radiation safety management and the shielding designs of facilities employing medical linear accelerators (LINACs). To this end, a questionnaire was used to collect information on LINAC facilities and treatments, workload, shielding design, shielding management, and path of obtaining shielding information. Out of 100 domestic institutions, 52 responded to the survey. Approximately 70% of the institutions utilized IMRT for more than 60% of their cases, and an IMRT factor of 5 was adopted by 75% of these institutions. Over 80% of the institutions accounted for the applied time-averaged dose rate per week and instantaneous dose equivalent rates in their shielding designs. Approximately 45% of the institutions obtained important shielding information via a radiation shielding design company and the NCRP-151 report. Overall, most facilities were shown to follow the standards recommended by the relevant international agencies. However, the requirement to establish standardized shielding design information and clarify ambiguous paths for information acquisition was also highlighted. Therefore, the study's results can be used as a foundation for establishing a safety control system and for creating adequate shielding designs.

The radiation resistance of Bacillus pumilus spores to gamma rays, X-rays, and electron beam (e-beam) was investigated using industrial irradiators operating at various dose rates. The dose rates were as follows: gamma 1 and 10 kGy/h; X-ray 10 and 200 kGy/h; e-beam 2000 kGy/h. The regression analysis showed that survivor curves were log10 linear for all three sources within the investigated absorbed dose range of 1–6 kGy, irrespective of the dose rate applied. All irradiation technologies were equally efficient to inactivate the spores, which is reflected in their comparable D-values (p > 0.05), and dose rate had no impact on the microbicidal efficacy. These results suggest that wherever a specified minimum dose is delivered, the sterilization dose can be trans ferred between irradiation technologies in industrial sterilization of medical devices without any impact on product sterility. These findings from a novel single study encompassing all available industrial radiation technologies for the purpose of medical devices sterilization, advance our understanding of microbial destruction as related to exposure to important sterilization modalities, which will help inform future applicability of these technologies for emerging industry opportunities. no

The dose rate of atomic bomb (A-bomb) radiation to the survivors has still remained unclear, although the dose–response data of A-bomb cancers has been taken as a standard in estimating the cancer risk of radiation and the dose and dose-rate effectiveness factor (DDREF). Since the applicability of the currently used DDREF of 2 derived from A-bomb data is limited in a narrow dose-rate range, 0.25-75 Gy/min as estimated from analysis of DS86 dosimetry data in the present study, a non-tumor dose (Dnt) was applied in an attempt to gain a more universal dose-rate effectiveness factor (DREF), where Dnt is an empirical parameter defined as the highest dose at which no statistically significant tumor increase is observed above the control level and its magnitude depends on the dose rate. The new DREF values were expressed as a function of the dose rate at four exposure categories, i.e. partial body low LET, whole body low linear energy transfer (LET), partial body high LET and whole body high LET and provided a value of 14 for environmental level radiation at a dose rate of 10−9 Gy/min for whole body low LET.

Purpose The aim of this study was to examine current practice patterns in pediatric total body irradiation (TBI) techniques among COG member institutions. Methods and Materials Between November 2019 and February 2020, a questionnaire containing 52 questions related to the technical aspects of TBI was sent to medical physicists at 152 COG institutions. The questions were designed to obtain technical information on commonly used TBI treatment techniques. Another set of 9 questions related to the clinical management of patients undergoing TBI was sent to 152 COG member radiation oncologists at the same institutions. Results Twelve institutions were excluded because TBI was not performed in their institutions. A total of 88 physicists from 88 institutions (63% response rate) and 96 radiation oncologists from 96 institutions (69% response rate) responded. The anterior-posterior/posterior-anterior (AP/PA) technique was the most common technique reported (49 institutions [56%]); 44 institutions (50%) used the lateral technique, and 14 (16%) used volumetric modulated arc therapy or tomotherapy. Midplane dose rates of 6 to 15 cGy/min were most commonly used. The most common specification for lung dose was the midlung dose for both AP/PA techniques (71%) and lateral techniques (63%). Almost all physician responders agreed with the need to refine current TBI techniques, and 79% supported the investigation of new TBI techniques to further lower the lung dose. Conclusions There was no consistency in the practice patterns, methods for dose measurement, and reporting of TBI doses among COG institutions. The lack of standardization precludes meaningful correlation between TBI doses and clinical outcomes including disease control and normal tissue toxicity. The COG radiation oncology discipline is currently undertaking several steps to standardize the practice and dose reporting of pediatric TBI using detailed questionnaires and phantom-based credentialing for all COG centers.

Background: The coccidian protozoan, Caryospora cheloniae, has been associated with severe enteritis and encephalitis in immature farm-raised green turtles (Chelonia mydas) in the Cayman Islands, immature green turtles off the coast of Florida, and immature stranded sea turtles in Australia. An effective anti-coccidial drug that is both orally absorbed and well-distributed throughout the body is needed for treatment of turtles diagnosed with coccidiosis in rehabilitation facilities. Ponazuril is a triazine antiprotozoal drug that is approved in the USA for the treatment of another Apicomplexan, Sarcocystis neurona, and has also been successfully used in the therapy of other coccidian parasites.Aim: To perform an oral dose-ranging pilot study (10-100 mg/kg of body weight ponazuril) in green turtles (N = 9), followed by oral administration of ponazuril at 100 mg/kg body weight (N = 8) to assess its disposition. Another goal of this study was to optimize the method of oral drug administration to green turtles.Method: Plasma ponazuril concentrations were quantified using high performance liquid chromatography (HPLC). Data were fit to standard compartmental models with first order absorption.Results: Ponazuril was absorbed after oral administration at 100 mg/kg BW, with a maximum plasma concentration of 3.3 µg/ml. Dose-dependent pharmacokinetic parameters only weakly correlated with the dose rate, apparently due to considerable pharmacokinetic variability observed between turtles. Administration of ponazuril in gelatin capsules using a balling gun was deemed the least variable and most successful method of drug administration.Conclusion: Further studies are needed to evaluate the safety and efficacy of ponazuril in sea turtles with coccidiosis.

This paper describes the development of a Microsoft (MS) Excel workbook calculator that estimates the dose rate of a neutron activated sample by calculating the activity and associated dose rate contributions of key isotopes. The goal of the calculator is to prove a simplified and reasonably accurate dose rate estimate that can be used by technicians, students, and instructors who routinely perform Neutron Activation Analysis on samples of known material compositions. Furthermore, the calculator can be used by personnel with little or no programming experience or access to more complicated analysis software. This paper outlines the research performed and assumptions made in the development of the calculator along with the methods used for testing its output. The calculator is mostly automated and requires no programming experience and only a limited knowledge of MS excel to operate. Though unable to compare against dose rates of activated sample results, this calculator provides activity result estimates within 5% of the Wise Uranium – Neutron Activation Calculator and a calculated exposure rate within 50% of the dose rates from gamma-ray constants.

Purification of fifteen NaCl samples from natural and different area in the middle and south of Iraq are prepared and studied the structural characteristics of samples by powder X-ray diffraction analysis at 𝛌=1.542Å. The present work considered the specific activities of naturally occurring radioactive materials in salt samples, which are measured and analyzed using high resolution HPGe system. Also, the radiological parameters have been considered in this work. The average specific concentration (in Bq.kg-1) of the salt samples is found 16.864.92 for 226Ra, 5.972.05 for 232Th and 9.852.8 for 40K, respectively, which are below the national levels, 40Bq.kg-1, 30Bq.kg-1 and 400Bq.kg-1, respectively (UNSCEAR, 2000). Similarly the absorb dose rates are in the range3.71 nGy.h-1 to 12.591nGy.h-1.The measured radiation hazard indices show that the concentrations of these radionuclides in all samples are within the allowable limits.

The cohorts of people formerly living at the Techa River shoreline in the Southern Urals, Russia, are widely studied cohorts for the investigation of low-dose radiation effects to human health. The nuclear facilities of the Mayak Production Association (PA) discharged their radioactive effluents into the nearby Techa River, especially in the first years of operation. Health status of cohort member data is constantly being improved and updated. Consequently, there is a need to also improve and verify the underlying dosimetry, which gives information about the dose of cohort members. For the Techa River population, the dosimetry is handled in the Techa River Dosimetry System (TRDS). The present work shows results of a feasibility study to validate the TRDS at the location of the village of Metlino, a village just 7 km downstream from the Mayak PA. For this settlement there were two sources of external exposure, the contaminated banks of the Techa River and the contaminated shoreline of the nearby Metlinsky Pond. In the present study the north-western wall of a granary was used as a dose archive to validate dose estimates. Measurements of doses in brick accumulated over many decades and measurements of the current dose rate in bricks were combined with dose rate measurements in air above ground in front of the granary, historical contamination data and Monte-Carlo simulations. Air kerma estimates for 1949–1956 significantly different from zero could not be reconstructed for the Metlinsky Pond shoreline near the granary, but an upper dose limit could be estimated. Implications for TRDS-2016 are discussed.

The accident at Fukushima Daiichi Nuclear Power Plant caused radioactive materials to spread outside the plant. To limit exposure in the area, air dose rates have been measured. When the dose rate exceeded the acceptable upper bound, the area was decontaminated by stripping the soil and washing roads. Immediately after the accident, it was not clear how much of an effect outdoor contamination had on dose rates inside houses. This paper discusses the effect of outdoor contamination on indoor air dose rates and factors influencing those dose rates based upon actual measurements taken of a wooden house standing on flat land in the area around the power plant. In addition, the effects of indoor horizontal distribution, height distribution, and decontamination are discussed using simple model simulations. As a result, the following was found, although within the range of air dose rates and location conditions measured in this study. Horizontal variation in indoor air dose rates decreases monotonically toward the centre of the house. Once decontamination has been performed, the overall dose rate decreases and variation becomes smaller. This trend is thought to be mainly due to expansion of a low-dose area. Vertical changes in indoor air dose rates are not straightforward. It is estimated that the dose rate decreases near the ground surface, then tends to increase going higher and finally decreases even higher up. This change in dose rates is thought to be due to the effect of radioactive materials permeating the soil. Recognition of the effects of these factors is important when estimating indoor air dose rates because indoor air dose rates are affected by the degree of decontamination, house size, and degree of penetration of radionuclides into the soil.

Ultra-high dose rate "FLASH" radiotherapy has been shown to drastically reduce normal tissue toxicities while being as efficacious as conventional dose rate radiotherapy to treat tumors. A large number of preclinical studies describing this so-called FLASH effect have led to the clinical translation of FLASH-RT using ultra-high dose rate electron and proton beams. Although the vast majority of radiation therapy treatments are delivered using x-rays, few preclinical data using ultra-high dose rate x-ray irradiation have been published. This review focuses on different methods that can be used to generate ultra-high dose rate x-rays and their beam characteristics along with their effect on the biological tissues and the perspectives for the development of FLASH-RT with x-rays. This article is protected by copyright. All rights reserved.

PURPOSE Intracavitary brachytherapy using High-Dose-Rate (HDR) and Low-dose-rate (LDR) in cervical cancer has been utilized. We report the long-term final results of a large randomized trial in terms of toxicities and efficacy. METHODS AND MATERIALS Between 1996 to 2005, 816 patients were randomized to LDR (n = 441 patients) or HDR brachytherapy (n = 369 patients) stratified by FIGO Stage grouping. Patients with Stage I-II received external irradiation of 40 Gy in 20 fractions (with midline block (MLB)) followed by either 2 LDR Intracavitary applications of 30 Gy to point A (2–3 weeks apart) or 5 HDR Intracavitary applications of 7 Gy to point A once weekly. Patients with Stage III received 50 Gy in 25 fractions (with MLB after 40 Gy) followed by either one application of LDR 30 Gy to point A or three applications of HDR 7 Gy to point A once weekly. RESULTS With a median follow-up was 64 months (interquartile range [IQR]: 21 - 111), moderate to severe rectal and bladder complications were higher in LDR arm as compared to HDR arm (9.7% vs. 3.6%; p = 0.02) and (10.5% vs. 5.5%; p = 0.06) for Stage I-II. No difference in rectal or bladder complications for Stage III patients. Disease free and overall survivals were similar in both the arms for all stages. CONCLUSIONS HDR intracavitary brachytherapy with 7 Gy per fraction weekly is superior to LDR in terms of late rectal and bladder complications. Local control rates and survivals are similar irrespective of stages.

Ionising radiation causes secondary tumours and/or enduring cognitive deficits, especially in children. Proton radiotherapy reduces exposure of the developing brain in children but may still cause some lasting effects. Recent observations show that ultra-high dose rate radiation treatment (≥40 Gy/s), called the FLASH effect, is equally effective at tumour control but less damaging to surrounding tissue compared with conventional dose rate protons (0.03–3 Gy/s). Most studies on the FLASH effect in brain and other tissues with different radiation modalities (electron and photon radiation), show FLASH benefits in these preclinical rodent models, but the data are limited, especially for proton FLASH, including for dose, dose rate and neurochemical and neurobehavioural outcomes. Tests of neurocognitive outcomes have been limited despite clinical evidence that this is the area of greatest concern. The FLASH effect in the context of proton exposure is promising, but a more systematic and comprehensive approach to outcomes is needed.

Microbeam radiotherapy (MRT) is the delivery of spatially fractionated beams that have the potential to offer significant improvements in the therapeutic ratio due to the delivery of micron-sized high dose and dose rate beams. They build on longstanding clinical experience of GRID radiotherapy and more recently lattice-based approaches. Here we briefly overview the preclinical evidence for MRT efficacy and highlight the challenges for bringing this to clinical utility. The biological mechanisms underpinning MRT efficacy are still unclear, but involve vascular, bystander, stem cell and potentially immune responses. There is probably significant overlap in the mechanisms underpinning MRT responses and FLASH radiotherapy that needs to be further defined. (c) 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Purpose To establish and investigate the effects of dose, linear energy transfer (LET), and O2 concentration on biologic response to ultrahigh dose rate (uHDR; FLASH) helium ion beams compared with standard dose rate (SDR) irradiation. Methods and Materials Beam delivery settings for raster-scanned helium ions at both uHDR and SDR were tuned to achieve >100 Gy/s and ∼0.1 Gy/s, respectively. For both SDR and uHDR, plan optimization and calibration for 10 × 10-mm 2 fields were performed to assess in vitro response at an LET range of 4.5 to 16 keV/µm. Clonogenic survival assay was conducted at doses ranging from 2 to 12 Gy in 2 human lung epithelial cell lines (A549 and H1437). Radiation-induced nuclear γH2AX foci (RIF) were assessed in both epithelial cell lines and primary human pulmonary fibroblasts. Results Average dose rates achieved were 185 Gy/s and 0.12 Gy/s for uHDR and SDR, respectively. No differences in cellular response to SDR versus uHDR were observed for all tested doses at 21% O2, and at 2 and 4 Gy at 1% O2. In contrast, at 1% O2 and a dose threshold of ≳8 Gy cell survival was higher and correlated with reduced nuclear γH2AX RIF signal, indicating FLASH sparing effect in the investigated cell lines irradiated with uHDR compared with SDR. Conclusions The first uHDR delivery of raster-scanned particle beams was achieved using helium ions, reaching FLASH-level dose-rates of >100 Gy/s. Baseline oxygen levels and delivered dose (≳8 Gy) play a pivotal role, irrespective of the studied cell lines, for observation of a sparing effect for helium ions.

BACKGROUND AND PURPOSE Despite the excellent clinical outcomes from brachytherapy treatments compared with other modalities and the low associated costs, there have been reports of a decline in utilization of brachytherapy. The aim of this study was to investigate in detail the trend in utilization of brachytherapy in the province of Quebec, Canada, from 2011 to 2019. MATERIALS AND METHODS All radiotherapy clinics in the province of Quebec, and among these the clinics that provide brachytherapy treatments, were identified. This observational retrospective cohort study involved analysis of data compiled by the Ministere de la Sante et des Services Sociaux du Quebec for the period of 2011 to end of 2019 on all brachytherapy procedures performed in the province of Quebec. Time series graphs were used to describe the number of high dose rate (HDR) and low dose rate (LDR) brachytherapy treatments during the studied time period. Statistical analysis was conducted using R statistical software. RESULTS Between 2011 and 2019, 12 hospitals in the province of Quebec provided radiotherapy treatments, and all of them offered brachytherapy services. The median annual number of brachytherapy sessions was 4413 (range 3930-4829). HDR brachytherapy represented over 90% of all brachytherapy treatments throughout the study period. Significant changes over time were observed in the number of treatments: at least 5% change was seen only for the two most common subtypes of brachytherapy, HDR interstitial and HDR intracavitary, with an increase of 9.6% and a decrease of 9.2%, respectively. The use of other subtypes of brachytherapy (HDR-plesiotherapy, LDR-interstitial, LDR-intracavitary, LDR-eye plaque) was stable between 2011 and 2019, with ≤ 2.5% variation. CONCLUSION This study demonstrates an overall steady use of brachytherapy between 2011 and 2019 in Quebec. Brachytherapy offers numerous advantages for the treatment of diverse cancer sites. Although more sophisticated external beam radiotherapy treatments have emerged in the last decades, the precision and cost-effectiveness of brachytherapy remain unbeaten. To ensure the continued use and availability of brachytherapy, governments must put in place policies and regulations to that effect. Training and exposure of future health care professionals to brachytherapy within Quebec and Canada is essential to provide all patients the same access to this life saving modality.

purpose This practice parameter aims to detail the processes, qualifications of personnel, patient selection, equipment, patient and personnel safety, documentation, and quality control and improvement necessary for an HDR brachytherapy program. Methods and Materials This practice parameter was revised collaboratively by the American College of Radiology (ACR), the American Brachytherapy Society (ABS), and the American Society for Radiation Oncology (ASTRO). Results Brachytherapy is a radiotherapeutic modality in which radionuclide or electronic sources are used to deliver a radiation dose at a distance of up to a few centimeters by surface, intracavitary, intraluminal, or interstitial application. Brachytherapy alone or combined with external beam radiotherapy plays an important role in the management and treatment of patients with cancer. High-dose-rate (HDR) brachytherapy uses radionuclides, such as iridium-192, at dose rates of ≥12 Gy/hr to a designated target point or volume, and it is an important treatment for a variety of malignant and benign conditions. Its use allows for application of high doses of radiation to defined target volumes with relative sparing of adjacent critical structures. Conclusions HDR brachytherapy requires detailed attention to personnel, equipment, patient and personnel safety, and continuing staff education. Coordination between the radiation oncologist and treatment planning staff and effective quality assurance procedures are important components of successful HDR brachytherapy programs.

The characteristics of the external radiation on the surface of the casks for spent nuclear fuel (SNF) storage by dry method are investigated for the case when the spatial distribution of SNF in the basket changes due to the destruction of the fuel rod claddings. The surface areas are determined, where the changes in fluxes of neutrons, produced by 244Cm actinide, and γ-quanta, produced by long-lived isotopes, are maximum in the result of the decrease in the height of the SNF area. Concrete (VSC-24) and metal (SC-21) casks are considered as examples. The procedure of periodic measurement of the dose rate of neutrons or γ-quanta at the specified points of the cask surface is proposed for identifying the fuel rod cladding destruction. Under normal operation, the decrease in the dose rate produced by neutrons as the function of SNF storage duration is determined by the half-life of 244Cm, and for γ-quanta - by the half-lives of long-lived SNF isotopes. Consequently, a stepwise change in the dose rate of neutrons or γ-quanta, detected by the measurements, as compared to the previous one, would indicate the destruction of the fuel rod claddings.

In recent decades, eye plaques of brachytherapy have been extensively used as primary treatment as well as a complementary treatment for ocular cancer. The purpose of this study is the development of the eye plaque brachytherapy throughout a new design of eye plaque by combining the COMS plaque and the CCB BEBIG plaque loaded by IRA1-103Pd and 106Ru, respectively. A new dual-core plaque with a diameter of 20 mm was designed in the way that the BEBIG plaque with a diameter of 20 mm loaded by 106Ru plate is attached to the COMS plaque with a diameter of 20 mm loaded by 24 of IRA1-103Pd seeds. Dose calculations for the new plaque were performed by using the MCNP5 code. Dose calculations of dual-core plaque including 103Pd seeds (gamma) and 106Ru plate (beta) were separately done for the sake of MCNP constraints in gamma and beta particle transfer simultaneously. The new dual-core plaque delivers a much higher dose rate to the tumor compared with every single plaque, while the dose rate reached to healthy tissues is slightly higher than each plaque separately. Of course, this is acceptable because the treatment time reduces and subsequently the error in radiation therapy reduces.

We review the current status of proton FLASH experimental systems, including preclinical physical and biological results. Technological limitations on preclinical investigation of FLASH biological mechanisms and determination of clinically relevant parameters are discussed. A review of the biological data reveals no reproduced proton FLASH effect in vitro and a significant in vivo FLASH sparing effect of normal tissue toxicity observed with multiple proton FLASH irradiation systems. Importantly, multiple studies suggest little or no difference in tumor growth delay for proton FLASH when compared to conventional dose rate proton radiation. A discussion follows on future areas of development with a focus on the determination of the optimal parameters for maximizing the therapeutic ratio between tumor and normal tissue response and ultimately clinical translation of proton FLASH radiation.

Purpose Our center adopted high-dose-rate brachytherapy with surface applicators (plesiotherapy) in 2008, creating custom molds to treat irregular areas. This study describes the efficacy and safety outcomes after extensive follow-up in the patients. Methods/patients We planned the treatment using two computed tomography (CT) scans: the first to delineate the lesion and the second after placing the thermoplastic mold. Fusing the two CT images enables planning of the target volume and pinpointing, where the catheters are in the mold. Results Seventy patients received plesiotherapy, either exclusively or following excision in patients with risk factors for recurrence. Those receiving plesiotherapy alone showed a complete response rate of 95.8%, and recurrences occurred in 5.7% at a mean follow-up of 96.2 months. Chronic toxicity appeared in 26.6% of patients, but severity was limited to grade 1 or 2. Conclusions High-dose-rate brachytherapy with customized molds yields a high rate of complete response, with long-term recurrence rates in line with similar studies and an acceptable toxicity rate.

The purpose of the study is to compare the excess relative risk (ERR per 1 Sv) of solid cancer mortality in acute - catastrophic or emergency, and occupational - fractionated or chronic exposure. Materials and research methods. A maintained database (database of sources) on nuclear workers from about 40 countries, on the basis of it a combined data analysis was carried out to determine the integral ERR value per 1 Gy for cancer mortality for comparison with parameters of cohorts exposed to catastrophic and emergency exposure: the LSS cohort victims of the atomic bombings in Japan, residents of the Techa River (radioactive contamination due to emissions from the Mayak plant) and Russian liquidators of the Chernobyl accident. Results. Comparison of the ERR per 1 Sv for cancer mortality for workers in the global nuclear industry (combining analysis of data from 37 studies) with the parameters of the LSS cohort, residents on the Techa River and liquidators of the Chernobyl accident showed the absence of logical and principial differences, and the risks for the last two cohorts were the highest. Although the data obtained partly confirm the approach of recent years by the United Nations Scientific Committee on the Effects of Atomic Radiation, according to which the carcinogenic effects of acute, accidental, and fractionated or chronic radiation exposure do not depend on the dose rate factor (DDREF), nevertheless, taking into account biological mechanisms and data radiobiological experiments, this issue cannot be considered unambiguously resolved. Conclusion. Based on the ERR per 1 Sv, the average external dose, and the annual background cancer mortality in Russia and the United States, the expected increase in cancer mortality for 100,000 nuclear workers will average 32-69 people over 10 years (0.032-0.069% of the group). Such risks, due to the many carcinogenic non-radiation factors of life and work, as well as fluctuations in the background value, cannot be taken into account in the practice of medicine and health care.

The aim of the study is to assess the main radiation-hazardous factors that determine the effective dose of personnel during underground uranium mining at the Priargunsky Industrial Mining and Chemical Association, and to summarize the data of the radiation control of the enterprise for 2016-2020. The main factors that create personnel dose loads are: the volume activity of short-lived daughter products of radon decay in the air, the dose rate of external gamma radiation, and the volume activity of long-lived alpha-emitting radionuclides of the uranium-radium series in industrial dust. Information on the structure and values of individual effective doses of workers is presented. Recommendations for improving the radiation monitoring system are given.

The dynamics of radionuclides in terrestrial environments is a crucial consideration for environmental remediation and radiation protection after a severe nuclear disaster. Although the dynamics of...

Background Over the last two decades, breast cancer remains the main cause of cancer deaths in women. To treat this type of cancer, radiation therapy (RT) has proved to be efficient. RT for breast cancer is, however, challenged by intrafractional motion caused by respiration. The problem is more severe for the left-sided breast cancer due to the proximity to the heart as an organ-at-risk. While particle therapy results in superior dose characteristics than conventional RT, due to the physics of particle interactions in the body, particle therapy is more sensitive to target motion. Conclusions This review highlights current and emerging strategies for the management of intrafractional target motion in breast cancer treatment with an emphasis on particle therapy, as a modern RT technique. There are major challenges associated with transferring real-time motion monitoring technologies from photon to particles beams. Surface imaging would be the dominant imaging modality for real-time intrafractional motion monitoring for breast cancer. The magnetic resonance imaging (MRI) guidance and ultra high dose rate (FLASH)-RT seem to be state-of-the-art approaches to deal with 4D RT for breast cancer.

To cope with the shortage of filtering facepiece respirators (FFRs) during the coronavirus (COVID-19) pandemic, healthcare institutions were forced to reuse FFRs after applying different decontamination methods including gamma-irradiation (GIR). The aim of this study was to evaluate the effect of GIR on the filtration efficiency (FE) of FFRs and on SARS-CoV-2 detection. The FE of 2 FFRs types (KN95 and N95-3 M masks) was assessed at different particle sizes (0.3–5 µm) following GIR (0–15 kGy) delivered at either typical (1.65 kGy/h) or low (0.5088 kGy/h) dose rates. The detection of two SARS-CoV-2 RNA genes (E and RdRp4) following GIR (0–50 kGy) was carried out using RT-qPCR assay. Both masks showed an overall significant (P P ≤ 0.001) in the cycle threshold values (ΔCt) of both genes, with no detection following high doses. In conclusion, complete degradation of SARS-CoV-2 RNA can be achieved by high GIR (≥ 30 kGy), suggesting its potential use in FFRs decontamination. However, GIR exhibited adverse effects on FE in dose- and particle size-dependent manners, rendering its use to decontaminate FFRs debatable.

Landfill sites are regarded as prominent sources of bioaerosols for the surrounding atmosphere. The present study focused on the emission of airborne bacteria and fungi in four seasons of a sanitary landfill site. The main species found in bioaerosols were assayed using high-throughput sequencing. The SourceTracker method was utilized to identify the sources of the bioaerosols present at the boundary of the landfill site. Furthermore, the health consequences of the exposure to bioaerosols were evaluated based on the average daily dose rates. Results showed that the concentrations of airborne bacteria in the operation area (OPA) and the leakage treatment area (LTA) were in the range of (4684 ± 477)-(10883 ± 1395) CFU/m3 and (3179 ± 453)-(9051 ± 738) CFU/m3, respectively. The average emission levels of fungal aerosols were 4026 CFU/m3 for OPA and 1295 CFU/m3 for LTA. The landfill site received the maximum bioaerosol load during summer and the minimum during winter. Approximately 41.39%- 86.24% of the airborne bacteria had a particle size of 1.1 to 4.7 µm, whereas 48.27%- 66.45% of the airborne fungi had a particle size of more than 4.7 µm. Bacillus sp., Brevibacillus sp., and Paenibacillus sp. were abundant in the bacterial population, whereas Penicillium sp. and Aspergillus sp. dominated the fungal population. Bioaerosols released from the working area and treatment of leachate were the two main sources that emerged in the surrounding air of the landfill site boundary. The exposure risks during summer and autumn were higher than those in spring and winter.

This study reports the gamma absorbed dose rate (GADR) in 88 locations within five different geological regions of Uttara Kannada district. The measurements were made using a UR-705 environmental radiation dosimeter. The outdoor gamma absorbed dose rate varies from 44.5 to 220.0 nGy h–1 with the mean value of 78.0 nGy h–1, which is 1.3 times higher than the international average value of 59 nGy h–1. The indoor gamma absorbed dose rate varies from 57.3 to 242.5 nGy h–1 with an average of 90.0 nGy h–1, which is slightly higher than the world average of 84 nGy h–1 as suggested by UNSCEAR-2000. The estimated dose rate varies with the geological background and soil type. The total AEDE ranges from 0.3 to 1.38 mSv year–1 with an average of 0.53 mSv year–1. The average total AEDE is lower than the dose limit of 1 mSv year–1 for public, suggested by ICRP-1991.

The article describes a model and method for calculating beta-exposure doses to secretory and basal cells of the tracheobronchial part of the respiratory tract when a point source of 1 Bq activity moves along the inner surface of respiratory formations. The calculations, that used for proposed model, were performed by using a 90Y point source as an example. The dose calculation model takes into account the speed o f movement of the radiation source in each respiratory formation, the size of the respiratory formations, and the depth of the secretory and basal cells. The dose calculation is based on the dose rate attenuation functions published by W. G. Cross et al. (DOI: 10.1097/00004032-199208000-00002). The calculations were performed for a cylindrical model of a respiratory formation. Two kinds of cells were considered for the dose estimation: cells irradiated without beta-particle exit into bronchial lumen (type 1 cells) and cells irradiated due to beta-par­ticle exit into bronchial lumen (type 2 cells). The results of calculations showed, that as far as the generation number increasing, the average irradiation doses of the type 1 cells are 10 or more times greater than those of the type 2 cells. With increasing generation number in the tracheobronchial tree, doses per cells increase by several orders of magnitude. The highest doses are formed in bronchioles of generations 9-15, reaching units and tens of mGy. In spite of the fact that the number of generation increases, the total number of irradiated cells decreases, the collective doses of irradiated cells (sum of doses to all cells of the respiratory formation) in the last generations are 30-50 times higher than the doses of the first generations. Thus, in case of a single point source, there is a significant (by many orders of magnitude) scatter of doses to individual cells in indi­vidual respiratory formation, as well as significant differences in average doses of trachea, individual bronchi and bronchioles.

We have studied the influence of high gamma doses and dose rates on the light output of bismuth orthogermanate (Bi4Ge3O12) crystals. The results demonstrate that the change in the light output of the Bi4Ge3O12 crystals at high gamma doses is due to the formation of color and trapping centers, which lead to degradation of the spectroscopic properties of the crystals.

Large doses of ionizing radiation delivered to tumors at ultra-high dose rates (i.e., in a few milliseconds) paradoxically spare the surrounding healthy tissue while preserving anti-tumor activity (compared with conventional radiotherapy delivered at much lower dose rates). This new modality is known as “FLASH radiotherapy” (FLASH-RT). Although the molecular mechanisms underlying FLASH-RT are not yet fully understood, it has been suggested that radiation delivered at high dose rates spares normal tissue via oxygen depletion followed by subsequent radioresistance of the irradiated tissue. To date, FLASH-RT has been studied using electrons, photons, and protons in various basic biological experiments, pre-clinical studies, and recently in a human patient. However, the efficacy of heavy ions, such as energetic carbon ions, under FLASH-RT conditions remains unclear. Given that living cells and tissues consist mainly of water, we set out to study, from a pure radiation chemistry perspective, the effects of ultra-high dose rates on the transient yields and concentrations of radiolytic species formed in water irradiated by 300-MeV per nucleon carbon ions (LET ∼ 11.6 keV/µm). This mimics irradiation in the “plateau” region of the depth–dose distribution of ions, i.e., in the “normal” tissue region in which the LET is rather low. We used Monte Carlo simulations of multiple, simultaneously interacting radiation tracks together with an “instantaneous pulse” irradiation model. Our calculations show a pronounced oxygen depletion around 0.2 μs, strongly suggesting, as with electrons, photons, and protons, that irradiation with energetic carbon ions at ultra-high dose rates is suitable for FLASH-RT.